Apollo Endosurgery to Present at June Investor Conferences
Apollo Endosurgery (Nasdaq:APEN) has announced its participation in two upcoming investor conferences in June 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Apollo Endosurgery (Nasdaq:APEN) has announced its participation in two upcoming investor conferences in June 2021. On June 2, management will engage in one-on-one virtual meetings at the 18th Annual Craig-Hallum Institutional Investor Conference. Later, on June 16-17, the team will present at the JMP Securities Life Sciences Conference, with a group presentation scheduled for June 17 at 3:30 PM ET. Apollo is recognized for its innovative, less invasive medical devices aimed at gastrointestinal procedures and operates in over 75 countries.
Details
News Market Reaction – APEN
The recorded move for APEN in the trading session of this news was +0.69%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
AUSTIN, TX / ACCESSWWIRE / June 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announced that management will participate in two investor conference events during the month of June 2021.
Conferences Apollo Endosurgery management will participate include:
Wednesday, June 2, 2021
18th Annual Craig-Hallum Institutional Investor Conference
Management will host one-on-one virtual meetings for institutional investors
Wednesday, June 16 and Thursday, June 17, 2021
JMP Securities Life Sciences Conference
Management will lead a group presentation at 3:30 pm Eastern Time on Thursday June 17
One-on-one virtual meetings available will be available for institutional investors
For more information about scheduling a one-on-one meeting with management, please contact a Craig-Hallum or JMP Securities institutional sales representative or Matt Kreps, Investor Relations for Apollo Endosurgery, at mkreps@darrowir.com.
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, X-Tack™ Endoscopic HeliX Tacking System and the ORBERA® Intragastric Balloon.
Apollo's common stock is traded on the Nasdaq Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.
Contact:
Apollo Endosurgery, Inc.
Stefanie Cavanaugh, 512-279-5100
investor-relations@apolloendo.com
Darrow Associates Investor Relations
Matt Kreps, 214-597-8200
mkreps@darrowir.com
SOURCE: Apollo Endosurgery, Inc.
View source version on accesswire.com:
https://www.accesswire.com/649901/Apollo-Endosurgery-to-Present-at-June-Investor-Conferences
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.